WASHINGTON — The wife of the late actor Patrick Swayze brought star power to a Capitol Hill news conference Wednesday to urge greater attention and federal resources to study pancreatic cancer, the disease that killed her husband in 2009.
Lisa Niemi Swayze, an actor, director and dancer, said that when the "Dirty Dancing" star was diagnosed, he said to her, "I'm a dead man."
Pancreatic cancer is the nation's fourth-leading cause of cancer deaths, with only a 6 percent survival rate five years after diagnosis. But it lags far behind other cancers in funding. Patrick Swayze lived 22 months after being diagnosed; 75 percent die within a year. Swayze was 57 when he died.
Dressed in purple — the signature color for pancreatic cancer activists — Lisa Swayze appeared with Sen. Sheldon Whitehouse, D-R.I., whose mother died of pancreatic cancer, and Rep. Leonard Lance, R-N.J., to support the Pancreatic Cancer Research and Education Act, which was introduced Wednesday in the House of Representatives and the Senate. The measure would give the disease a higher priority, even during tough fiscal times.
Why the lack of attention to pancreatic cancer?
"It's a mystery," Swayze said. But she noted that other cancers have become high profile and benefited from more funding and more research, so "there are survivors championing their cause."
With so few survivors of pancreatic cancer, she told a room of friends and family members of the deceased, "it's up to us."
Pancreatic cancer is usually a silent killer, with few symptoms until the tumor has metastasized.
The Pancreatic Cancer Action Network released a report Wednesday that concludes that federal funding lagged for pancreatic cancer and the low research priority hurt survivor rates.
"For 40 years, the survival rate for pancreatic cancer has remained in the single digits, despite an increase in the incidence of the disease, despite the fact that it is the fourth-leading cause of cancer death and at a time when significant progress has been made on other cancers," network president Julie Fleshman said.
Research dedicated to pancreatic cancer receives 2 percent of the federal dollars that the National Cancer Institute distributes.